The PopVax Chronicles
Subscribe
Sign in
Home
Archive
About
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1
PopVax’s influenza vaccine designs elicit as much as 250x greater antibody titer against seasonal strains than existing approved flu vaccines, as well…
Jan 3
•
Soham Sankaran
3
Share this post
The PopVax Chronicles
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1
Copy link
Facebook
Email
Notes
More
December 2024
PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA…
We have some exciting news to share:
Dec 22, 2024
•
PopVax
2
Share this post
The PopVax Chronicles
PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA delivery work
Copy link
Facebook
Email
Notes
More
August 2023
The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
Broadly-protective mRNA vaccines to save millions of lives
Aug 20, 2023
•
Soham Sankaran
17
Share this post
The PopVax Chronicles
The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
